Fig. 2From: 18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysisRelation between event-free survival (EFS) and baseline tumor standardized uptake value (SUV)max (a), SUVmean (b), SUVpeak (c) in 143 patients with ER+/HER2- breast cancerBack to article page